<?xml version="1.0" encoding="UTF-8"?><inno:dom xmlns:inno="http://innodatalabs.com/innodom"><inno:meta/><inno:content><inno:text id="text-1" type="text"><inno:block page="1" page-height="512" page-width="396" x-max="239.0" x-min="164.0" y-max="42.0" y-min="21.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-1-</inno:font></inno:block></inno:text><inno:text id="text-2" type="text"><inno:block page="1" page-height="512" page-width="396" x-max="338.0" x-min="56.0" y-max="80.0" y-min="42.1"><inno:b><inno:color rgb="#bdae86"><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="16.00pt">CSA Staff Notice 51-362</inno:font><inno:br/><inno:font font-name="TimesNewRomanPS-BoldItalicMT" font-size="16.00pt"><inno:i>Staff Review of COVID-19 Disclosures and Guide for Disclosure<inno:br/>Improvements</inno:i></inno:font></inno:color></inno:b></inno:block></inno:text><inno:text id="text-3" type="text"><inno:block page="1" page-height="512" page-width="396" x-max="107.0" x-min="43.0" y-max="104.0" y-min="95.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="12.00pt">February 25, 2021</inno:font></inno:b></inno:block></inno:text><inno:text id="text-4" type="text"><inno:block page="1" page-height="512" page-width="396" x-max="103.0" x-min="43.0" y-max="125.0" y-min="114.0"><inno:b><inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="16.00pt">Introduction</inno:font></inno:color></inno:b></inno:block></inno:text><inno:text id="text-5" type="text"><inno:block page="1" page-height="512" page-width="396" x-max="351.0" x-min="43.0" y-max="184.0" y-min="130.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">The Canadian Securities Administrators (</inno:font><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">CSA</inno:font></inno:b><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">) have prepared this Staff Notice (</inno:font><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Notice</inno:font></inno:b><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">) to report the<inno:br/>results of recently completed continuous disclosure reviews (</inno:font><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">reviews</inno:font></inno:b><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">) conducted by CSA staff (</inno:font><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">staff or<inno:br/>we</inno:font></inno:b><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">) of the disclosures provided by reporting issuers</inno:font><inno:font font-name="TimesNewRomanPSMT" font-size="6.40pt"><inno:sup>1</inno:sup></inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">on the impact of COVID-19 to their business. Since<inno:br/>the World Health Organization declared COVID-19 as a pandemic on March 11, 2020, COVID-19 has<inno:br/>had a material adverse impact on the economy and is posing widespread business challenges for many<inno:br/>issuers, including reporting on and disclosing the business impact of COVID-19.</inno:font></inno:block></inno:text><inno:text id="text-6" type="text"><inno:block page="1" page-height="512" page-width="396" x-max="351.0" x-min="43.0" y-max="224.0" y-min="187.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">This issue-oriented review assessed compliance of issuers’ disclosures of the current and anticipated<inno:br/>impacts related to COVID-19 on their respective operations, financial condition, liquidity and future<inno:br/>prospects. The reviews also assessed key financial reporting areas applicable to issuers that may be<inno:br/>subject to significant judgement and measurement uncertainty in the current environment.</inno:font></inno:block></inno:text><inno:text id="text-7" type="text"><inno:block page="1" page-height="512" page-width="396" x-max="351.0" x-min="43.0" y-max="273.0" y-min="229.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">We recognize that issuers are preparing disclosure in a rapidly changing environment. However,<inno:br/>meaningful disclosures about the business impacts and potential uncertainties regarding COVID-19 are<inno:br/>needed for investors to make informed investment decisions. This Notice summarizes our key review<inno:br/>findings and includes some disclosure examples and guidance to assist reporting issuers and their advisors<inno:br/>with disclosing and reporting on the impact of COVID-19 to their business and operations.</inno:font></inno:block></inno:text><inno:text id="text-8" type="text"><inno:block page="1" page-height="512" page-width="396" x-max="351.0" x-min="43.0" y-max="322.0" y-min="276.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">We will continue to closely monitor issuers’ continuous disclosure (</inno:font><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">CD</inno:font></inno:b><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">) filings in relation to the impact<inno:br/>of the COVID-19 pandemic as part of our ongoing CSA CD review program. For further details, see CSA<inno:br/>Staff Notice 51-312 (revised)</inno:font> <inno:font font-name="TimesNewRomanPS-ItalicMT" font-size="11.00pt"><inno:i>Harmonized Continuous Disclosure Review Program</inno:i></inno:font><inno:font font-name="TimesNewRomanPSMT" font-size="6.40pt"><inno:sup>2</inno:sup></inno:font><inno:font font-name="TimesNewRomanPS-ItalicMT" font-size="11.00pt"><inno:i>.</inno:i></inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">An issuer’s<inno:br/>disclosure relating to the impacts and risk factors of the COVID-19 pandemic may also be assessed as<inno:br/>part of staff’s review of prospectus filings in connection with public offerings.</inno:font></inno:block></inno:text><inno:text id="text-9" type="text"><inno:block page="1" page-height="512" page-width="396" x-max="336.0" x-min="43.0" y-max="460.0" y-min="442.0"><inno:font font-name="Calibri" font-size="11.00pt">1</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="9.00pt">In this Notice “issuers” means those reporting issuers contemplated in National Instrument 51-102</inno:font> <inno:font font-name="TimesNewRomanPS-ItalicMT" font-size="9.00pt"><inno:i>Continuous Disclosure<inno:br/>Obligations</inno:i></inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="9.00pt">(</inno:font><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="9.00pt">NI 51-102</inno:font></inno:b><inno:font font-name="TimesNewRomanPSMT" font-size="9.00pt">).</inno:font></inno:block></inno:text><inno:text id="text-10" type="text"><inno:block page="1" page-height="512" page-width="396" x-max="300.0" x-min="43.0" y-max="482.0" y-min="466.0"><inno:font font-name="Calibri" font-size="11.00pt">2</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="9.00pt">Additional regulatory guidance on COVID-19 can be accessed at the CSA COVID-19 Information Hub at</inno:font><inno:br/><inno:color rgb="#0000ff"><inno:font font-name="TimesNewRomanPSMT" font-size="9.00pt"><inno:u>https://www.securities-administrators.ca/aboutcsa.aspx?id=1885</inno:u></inno:font></inno:color><inno:font font-name="TimesNewRomanPSMT" font-size="9.00pt">.</inno:font></inno:block></inno:text><inno:text id="text-11" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="201.0" x-min="194.0" y-max="33.0" y-min="24.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-2-</inno:font></inno:block></inno:text><inno:text id="text-12" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="156.0" x-min="43.0" y-max="57.0" y-min="45.0"><inno:b><inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="18.00pt">Contents of the Notice</inno:font></inno:color></inno:b></inno:block></inno:text><inno:text id="text-13" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="351.0" x-min="43.0" y-max="87.9" y-min="81.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">Introduction......................................................................................................................................1</inno:font></inno:block></inno:text><inno:text id="text-14" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="351.0" x-min="43.0" y-max="99.0" y-min="88.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">Part 1 - Executive Summary............................................................................................................3</inno:font></inno:block></inno:text><inno:text id="text-15" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="351.0" x-min="43.0" y-max="111.0" y-min="102.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">Part 2 - Scope and Methodology.....................................................................................................3</inno:font></inno:block></inno:text><inno:text id="text-16" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="351.0" x-min="43.0" y-max="123.9" y-min="115.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">Part 3 - Summary of Results and Key Themes................................................................................5</inno:font></inno:block></inno:text><inno:text id="text-17" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="351.0" x-min="43.0" y-max="136.0" y-min="124.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">Appendix A – Key Observations and Considerations.....................................................................8</inno:font></inno:block></inno:text><inno:text id="text-18" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="93.0" x-min="54.0" y-max="147.0" y-min="136.1"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">A.1 MD&amp;A</inno:font></inno:block></inno:text><inno:text id="text-19" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="127.0" x-min="93.1" y-max="149.0" y-min="136.1"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">Reporting.</inno:font></inno:block></inno:text><inno:text id="text-20" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="351.0" x-min="53.0" y-max="161.0" y-min="150.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">A.2 Financial Statements...........................................................................................................13</inno:font></inno:block></inno:text><inno:text id="text-21" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="351.0" x-min="51.0" y-max="172.0" y-min="161.1"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">A.3 Other Regulatory Matters...................................................................................................18</inno:font></inno:block></inno:text><inno:text id="text-22" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="351.0" x-min="43.0" y-max="185.0" y-min="175.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">Appendix B – Disclosure Examples..............................................................................................21</inno:font></inno:block></inno:text><inno:text id="text-23" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="351.0" x-min="55.0" y-max="196.9" y-min="187.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">B.1 MD&amp;A Disclosure Examples.............................................................................................21</inno:font></inno:block></inno:text><inno:text id="text-24" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="351.0" x-min="56.0" y-max="209.0" y-min="197.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">B.1.1 Discussion of Operations and the Impact of COVID-19..............................................21</inno:font></inno:block></inno:text><inno:text id="text-25" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="351.0" x-min="58.0" y-max="222.0" y-min="209.1"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">B.1.2 Discussion of Strategies Related to COVID-19...........................................................22</inno:font></inno:block></inno:text><inno:text id="text-26" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="351.0" x-min="59.0" y-max="233.0" y-min="222.1"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">B.1.3 Liquidity and Capital Resources...................................................................................22</inno:font></inno:block></inno:text><inno:text id="text-27" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="351.0" x-min="57.0" y-max="248.0" y-min="236.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">B.1.4 Risk Factor Disclosure..................................................................................................23</inno:font></inno:block></inno:text><inno:text id="text-28" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="351.0" x-min="54.0" y-max="260.9" y-min="249.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">B.2 Financial Statements Examples..........................................................................................24</inno:font></inno:block></inno:text><inno:text id="text-29" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="351.0" x-min="57.0" y-max="273.0" y-min="261.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">B.2.1 Impairment of Non-Financial Assets............................................................................24</inno:font></inno:block></inno:text><inno:text id="text-30" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="351.0" x-min="58.0" y-max="286.9" y-min="274.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">B.2.2 Going Concern..............................................................................................................25</inno:font></inno:block></inno:text><inno:text id="text-31" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="351.0" x-min="59.0" y-max="299.0" y-min="287.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">B.2.3 Government Assistance................................................................................................26</inno:font></inno:block></inno:text><inno:text id="text-32" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="351.0" x-min="55.0" y-max="310.0" y-min="300.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">B.3 Other Regulatory Matters Examples...................................................................................27</inno:font></inno:block></inno:text><inno:text id="text-33" type="text"><inno:block page="2" page-height="512" page-width="396" x-max="351.0" x-min="58.0" y-max="324.0" y-min="314.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">B.3.1 Non-GAAP Financial Measures...................................................................................27</inno:font></inno:block></inno:text><inno:text id="text-34" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="201.0" x-min="194.0" y-max="33.0" y-min="24.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-3-</inno:font></inno:block></inno:text><inno:text id="text-35" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="172.0" x-min="43.0" y-max="56.0" y-min="42.0"><inno:b><inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="16.00pt">Part 1 - Executive Summary</inno:font></inno:color></inno:b></inno:block></inno:text><inno:text id="text-36" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="352.0" x-min="43.0" y-max="88.0" y-min="61.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">The COVID-19 pandemic has significantly impacted the financial condition, financial performance,<inno:br/>operations and cash flows of reporting issuers of varying sizes and industries. This has specific financial<inno:br/>reporting implications for issuers.</inno:font></inno:block></inno:text><inno:text id="text-37" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="352.0" x-min="43.0" y-max="180.0" y-min="94.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">We were encouraged by the quality of disclosures provided by many issuers significantly impacted by<inno:br/>COVID-19. However, we noted certain areas where boiler-plate disclosure was provided regarding the<inno:br/>current and expected impact of COVID-19 on an issuer’s business with insufficient detail of entity-<inno:br/>specific COVID-19 related risks, including but not limited to, the nature and extent of credit risks and<inno:br/>liquidity uncertainties. We also observed instances of unbalanced or overly promotional disclosure and<inno:br/>isolated non-compliance for non-GAAP financial measures (</inno:font><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">NGM</inno:font></inno:b><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">s) and forward-looking information<inno:br/>(</inno:font><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">FLI</inno:font></inno:b><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">). It is important for issuers to tailor their disclosures to provide investors with an entity-specific<inno:br/>level of insight to understand the operational challenges, financial impacts, risk profile and the issuer’s<inno:br/>operational responses related to the COVID-19 pandemic. Such information is necessary to meet<inno:br/>securities requirements and to help foster investor confidence in the current environment.</inno:font></inno:block></inno:text><inno:text id="text-38" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="352.0" x-min="43.0" y-max="205.0" y-min="184.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">The reviews have resulted in outcomes where no action was required, requests for prospective disclosure<inno:br/>enhancements were made, or communication is ongoing to resolve the identified issues.</inno:font></inno:block></inno:text><inno:text id="text-39" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="323.0" x-min="43.0" y-max="221.0" y-min="208.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">At a high level, we emphasize the following for issuers to consider in their upcoming CD filings:</inno:font></inno:block></inno:text><inno:text id="text-40" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="345.0" x-min="51.0" y-max="245.0" y-min="225.0"><inno:nec bbox="82.4 428.93 87.45 432.86" cid="1" code="0xf0b7" fid="24:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">There is no “one size fits all” model for issuers to follow when assessing the disclosure<inno:br/>implications of COVID-19.</inno:font></inno:block></inno:text><inno:text id="text-41" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="227.0" x-min="53.0" y-max="254.0" y-min="246.0"><inno:nec bbox="84.0 402.73 89.05 406.66" cid="1" code="0xf0b7" fid="24:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Disclosures are expected to be transparent and balanced.</inno:font></inno:block></inno:text><inno:text id="text-42" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="268.0" x-min="53.0" y-max="263.0" y-min="254.1"><inno:nec bbox="84.0 389.23 89.05 393.16" cid="1" code="0xf0b7" fid="24:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Provide disclosures on COVID-19 that facilitates an understanding of:</inno:font></inno:block></inno:text><inno:text id="text-43" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="345.0" x-min="75.0" y-max="279.0" y-min="263.1"><inno:font font-name="CourierNewPSMT" font-size="11.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">The current and expected impact of COVID-19 on the issuer’s operations and financial<inno:br/>condition, including liquidity and capital resources.</inno:font></inno:block></inno:text><inno:text id="text-44" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="277.0" x-min="77.0" y-max="288.0" y-min="280.0"><inno:font font-name="CourierNewPSMT" font-size="11.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">The key risks that the COVID-19 pandemic presents to the issuer.</inno:font></inno:block></inno:text><inno:text id="text-45" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="345.0" x-min="77.0" y-max="313.9" y-min="289.0"><inno:font font-name="CourierNewPSMT" font-size="11.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Known trends, demands, events or uncertainties related to COVID-19 that management<inno:br/>reasonably believes will materially affect the issuer’s future revenues, expenses or<inno:br/>projects.</inno:font></inno:block></inno:text><inno:text id="text-46" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="345.0" x-min="77.0" y-max="330.0" y-min="314.0"><inno:font font-name="CourierNewPSMT" font-size="11.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">The operational changes and other measures taken by management in response to<inno:br/>COVID-19.</inno:font></inno:block></inno:text><inno:text id="text-47" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="345.0" x-min="77.0" y-max="355.9" y-min="330.1"><inno:font font-name="CourierNewPSMT" font-size="11.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">How COVID-19 has impacted the issuer’s capacity to meet working capital<inno:br/>requirements, debt covenants, planned growth or funding of future development activities<inno:br/>and capital expenditures.</inno:font></inno:block></inno:text><inno:text id="text-48" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="345.0" x-min="77.0" y-max="373.0" y-min="356.0"><inno:font font-name="CourierNewPSMT" font-size="11.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">How the COVID-19 pandemic has impacted areas of financial reporting subject to<inno:br/>significant judgement and measurement uncertainty in the current environment.</inno:font></inno:block></inno:text><inno:text id="text-49" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="345.0" x-min="77.0" y-max="404.9" y-min="373.1"><inno:font font-name="CourierNewPSMT" font-size="11.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">How the issuer has assessed impairment of non-financial assets given the extended<inno:br/>impact of the COVID-19 pandemic. Where applicable, sensitivity analysis and<inno:br/>disclosures relating to key assumptions will be especially important and should be both<inno:br/>realistic and supportable.</inno:font></inno:block></inno:text><inno:text id="text-50" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="345.0" x-min="76.0" y-max="425.0" y-min="405.0"><inno:font font-name="CourierNewPSMT" font-size="12.00pt">o</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">The accounting policy for, and nature and extent of government grants recognized in the<inno:br/>financial statements.</inno:font></inno:block></inno:text><inno:text id="text-51" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="189.0" x-min="43.0" y-max="447.0" y-min="432.0"><inno:b><inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="16.00pt">Part 2 - Scope and Methodology</inno:font></inno:color></inno:b></inno:block></inno:text><inno:text id="text-52" type="text"><inno:block page="3" page-height="512" page-width="396" x-max="352.0" x-min="43.0" y-max="472.0" y-min="451.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Staff took a risk-based approach in the selection of issuers by considering both qualitative and<inno:br/>quantitative criteria. Issuers selected for review included those identified as being materially impacted</inno:font></inno:block></inno:text><inno:text id="text-53" type="text"><inno:block page="4" page-height="512" page-width="396" x-max="201.0" x-min="193.0" y-max="33.0" y-min="22.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-4-</inno:font></inno:block></inno:text><inno:text id="text-54" type="text"><inno:block page="4" page-height="512" page-width="396" x-max="351.0" x-min="39.0" y-max="62.0" y-min="41.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">(both positively and adversely) by the COVID-19 pandemic in terms of their operations and financial<inno:br/>performance, as well as issuers that appeared to have a higher risk of impairment and/or financial distress.</inno:font></inno:block></inno:text><inno:text id="text-55" type="text"><inno:block page="4" page-height="512" page-width="396" x-max="351.0" x-min="39.0" y-max="95.0" y-min="65.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Staff examined the CD filings of approximately 90 issuers, focusing on the disclosures of the most recent<inno:br/>interim reporting period ending September 30, 2020 for issuers with a calendar financial year end. The<inno:br/>issuers selected for review varied by size and by industry as illustrated in the charts below:</inno:font></inno:block></inno:text><inno:text id="text-56" type="text"><inno:block page="4" page-height="512" page-width="396" x-max="73.0" x-min="39.0" y-max="108.0" y-min="100.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Figure #1</inno:font></inno:b></inno:block></inno:text><inno:image id="image-1" type="image"><inno:block page="4" page-height="512" page-width="396" x-max="350.0" x-min="44.0" y-max="224.0" y-min="113.0"/></inno:image><inno:text id="text-57" type="text"><inno:block page="4" page-height="512" page-width="396" x-max="351.0" x-min="39.0" y-max="273.0" y-min="229.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Our reviews primarily focused on issuers’ disclosure obligations under National Instrument 51-102</inno:font><inno:br/><inno:font font-name="TimesNewRomanPS-ItalicMT" font-size="11.00pt"><inno:i>Continuous Disclosure Obligations</inno:i></inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">(</inno:font><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">NI 51-102</inno:font></inno:b><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">). We also assessed compliance with certain recognition,<inno:br/>measurement and disclosure requirements in International Financial Reporting Standards (</inno:font><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">IFRS</inno:font></inno:b><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">) and<inno:br/>compliance with CSA Staff Notice 52-306</inno:font> <inno:font font-name="TimesNewRomanPS-ItalicMT" font-size="11.00pt"><inno:i>(Revised) – Non-GAAP Financial Measures</inno:i></inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">(</inno:font><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">SN 52-306</inno:font></inno:b><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">). The<inno:br/>following outlines the focus areas of the reviews conducted:</inno:font></inno:block></inno:text><inno:text id="text-58" type="text"><inno:block page="4" page-height="512" page-width="396" x-max="107.9" x-min="39.0" y-max="464.0" y-min="273.1"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">MD&amp;A<inno:br/>Financial<inno:br/>Statements<inno:br/>Other</inno:font></inno:b></inno:block></inno:text><inno:text id="text-59" type="text"><inno:block page="4" page-height="512" page-width="396" x-max="96.0" x-min="52.0" y-max="480.0" y-min="464.1"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Regulatory<inno:br/>Requirements</inno:font></inno:b></inno:block></inno:text><inno:text id="text-60" type="text"><inno:block page="4" page-height="512" page-width="396" x-max="264.0" x-min="109.0" y-max="294.0" y-min="279.0"><inno:nec bbox="170.5 341.63 175.55 345.56" cid="1" code="0xf0b7" fid="24:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Overall performance and discussion of operations</inno:font></inno:color></inno:block></inno:text><inno:text id="text-61" type="text"><inno:block page="4" page-height="512" page-width="396" x-max="237.0" x-min="112.1" y-max="302.9" y-min="294.1"><inno:nec bbox="170.5 328.13 175.55 332.06" cid="1" code="0xf0b7" fid="24:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Known trends, events and uncertainties</inno:font></inno:color></inno:block></inno:text><inno:text id="text-62" type="text"><inno:block page="4" page-height="512" page-width="396" x-max="214.0" x-min="108.0" y-max="310.0" y-min="303.0"><inno:nec bbox="170.5 314.63 175.55 318.56" cid="1" code="0xf0b7" fid="24:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Liquidity and capital resources</inno:font></inno:color></inno:block></inno:text><inno:text id="text-63" type="text"><inno:block page="4" page-height="512" page-width="396" x-max="168.0" x-min="112.1" y-max="320.0" y-min="312.0"><inno:nec bbox="170.5 301.13 175.55 305.06" cid="1" code="0xf0b7" fid="24:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Debt covenants</inno:font></inno:color></inno:block></inno:text><inno:text id="text-64" type="text"><inno:block page="4" page-height="512" page-width="396" x-max="185.0" x-min="108.0" y-max="333.0" y-min="321.0"><inno:nec bbox="170.5 287.63 175.55 291.56" cid="1" code="0xf0b7" fid="24:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Risk factor disclosure</inno:font></inno:color></inno:block></inno:text><inno:text id="text-65" type="text"><inno:block page="4" page-height="512" page-width="396" x-max="221.0" x-min="109.0" y-max="363.9" y-min="356.0"><inno:nec bbox="170.5 232.23 175.55 236.16" cid="1" code="0xf0b7" fid="24:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Impairment of non-financial assets</inno:font></inno:color></inno:block></inno:text><inno:text id="text-66" type="text"><inno:block page="4" page-height="512" page-width="396" x-max="167.0" x-min="110.0" y-max="373.0" y-min="364.0"><inno:nec bbox="170.5 218.73 175.55 222.66" cid="1" code="0xf0b7" fid="24:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Going concern</inno:font></inno:color></inno:block></inno:text><inno:text id="text-67" type="text"><inno:block page="4" page-height="512" page-width="396" x-max="277.0" x-min="109.0" y-max="381.9" y-min="374.0"><inno:nec bbox="170.5 205.23 175.55 209.16" cid="1" code="0xf0b7" fid="24:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Significant judgements and measurement uncertainties</inno:font></inno:color></inno:block></inno:text><inno:text id="text-68" type="text"><inno:block page="4" page-height="512" page-width="396" x-max="188.0" x-min="112.0" y-max="391.0" y-min="382.0"><inno:nec bbox="170.5 191.73 175.55 195.66" cid="1" code="0xf0b7" fid="24:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Expected credit losses</inno:font></inno:color></inno:block></inno:text><inno:text id="text-69" type="text"><inno:block page="4" page-height="512" page-width="396" x-max="251.0" x-min="110.0" y-max="399.0" y-min="391.1"><inno:nec bbox="170.5 178.23 175.55 182.16" cid="1" code="0xf0b7" fid="24:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Fair value changes for the real estate industry</inno:font></inno:color></inno:block></inno:text><inno:text id="text-70" type="text"><inno:block page="4" page-height="512" page-width="396" x-max="227.0" x-min="112.1" y-max="405.9" y-min="400.0"><inno:nec bbox="170.5 164.73 175.55 168.66" cid="1" code="0xf0b7" fid="24:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Financial instrument risk disclosures</inno:font></inno:color></inno:block></inno:text><inno:text id="text-71" type="text"><inno:block page="4" page-height="512" page-width="396" x-max="189.0" x-min="111.0" y-max="416.0" y-min="406.0"><inno:nec bbox="170.5 151.23 175.55 155.16" cid="1" code="0xf0b7" fid="24:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Government assistance</inno:font></inno:color></inno:block></inno:text><inno:text id="text-72" type="text"><inno:block page="4" page-height="512" page-width="396" x-max="298.0" x-min="109.0" y-max="426.0" y-min="417.0"><inno:nec bbox="170.5 137.73 175.55 141.66" cid="1" code="0xf0b7" fid="24:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">COVID-19 related amendments to IFRS 16</inno:font> <inno:font font-name="TimesNewRomanPS-ItalicMT" font-size="11.00pt"><inno:i>Leases</inno:i></inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">for lessees</inno:font></inno:color></inno:block></inno:text><inno:text id="text-73" type="text"><inno:block page="4" page-height="512" page-width="396" x-max="144.0" x-min="108.0" y-max="457.0" y-min="444.0"><inno:nec bbox="171.1 87.93 176.15 91.86" cid="1" code="0xf0b7" fid="24:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">NGMs</inno:font></inno:color></inno:block></inno:text><inno:text id="text-74" type="text"><inno:block page="4" page-height="512" page-width="396" x-max="133.0" x-min="110.0" y-max="466.0" y-min="458.0"><inno:nec bbox="171.1 74.43 176.15 78.36" cid="1" code="0xf0b7" fid="24:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">FLI</inno:font></inno:color></inno:block></inno:text><inno:text id="text-75" type="text"><inno:block page="4" page-height="512" page-width="396" x-max="195.0" x-min="109.0" y-max="476.9" y-min="468.0"><inno:nec bbox="171.1 60.93 176.15 64.86" cid="1" code="0xf0b7" fid="24:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Material change reporting</inno:font></inno:color></inno:block></inno:text><inno:text id="text-76" type="text"><inno:block page="4" page-height="512" page-width="396" x-max="192.0" x-min="110.0" y-max="485.0" y-min="477.0"><inno:nec bbox="171.1 47.43 176.15 51.36" cid="1" code="0xf0b7" fid="24:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Promotional disclosures</inno:font></inno:color></inno:block></inno:text><inno:text id="text-77" type="text"><inno:block page="5" page-height="512" page-width="396" x-max="201.0" x-min="193.0" y-max="33.0" y-min="22.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-5-</inno:font></inno:block></inno:text><inno:text id="text-78" type="text"><inno:block page="5" page-height="512" page-width="396" x-max="249.0" x-min="42.0" y-max="75.0" y-min="62.0"><inno:b><inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="16.00pt">Part 3 - Summary of Results and Key Themes</inno:font></inno:color></inno:b></inno:block></inno:text><inno:text id="text-79" type="text"><inno:block page="5" page-height="512" page-width="396" x-max="324.0" x-min="42.0" y-max="100.0" y-min="81.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Our reviews covered a variety of industries and highlighted the diverse impacts of the COVID-19<inno:br/>pandemic on issuers’ operations and businesses. Some of these impacts included:</inno:font></inno:block></inno:text><inno:image id="image-2" type="image"><inno:block page="5" page-height="512" page-width="396" x-max="347.0" x-min="44.0" y-max="258.0" y-min="108.0"/></inno:image><inno:text id="text-80" type="text"><inno:block page="5" page-height="512" page-width="396" x-max="319.0" x-min="42.0" y-max="284.0" y-min="263.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Issuers adjusted their operations in numerous ways to manage the impact of COVID-19 on their<inno:br/>operations and liquidity. Various measures/operational responses disclosed by issuers included:</inno:font></inno:block></inno:text><inno:text id="text-81" type="text"><inno:block page="5" page-height="512" page-width="396" x-max="97.0" x-min="59.0" y-max="390.0" y-min="330.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Measures<inno:br/>Taken to<inno:br/>Reduce<inno:br/>COVID-19<inno:br/>Impact/<inno:br/>Operational<inno:br/>Responses</inno:font></inno:b></inno:block></inno:text><inno:text id="text-82" type="text"><inno:block page="5" page-height="512" page-width="396" x-max="228.0" x-min="119.0" y-max="307.0" y-min="292.0"><inno:nec bbox="187.6 322.93 192.65 326.86" cid="1" code="0xf0b7" fid="24:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Government assistance programs</inno:font></inno:color></inno:block></inno:text><inno:text id="text-83" type="text"><inno:block page="5" page-height="512" page-width="396" x-max="226.0" x-min="119.0" y-max="313.0" y-min="307.1"><inno:nec bbox="187.6 309.43 192.65 313.36" cid="1" code="0xf0b7" fid="24:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Change in product or service mix</inno:font></inno:color></inno:block></inno:text><inno:text id="text-84" type="text"><inno:block page="5" page-height="512" page-width="396" x-max="300.0" x-min="118.0" y-max="323.9" y-min="315.0"><inno:nec bbox="187.6 295.93 192.65 299.86" cid="1" code="0xf0b7" fid="24:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Reduction in discretionary expenses</inno:font></inno:color></inno:block></inno:text><inno:text id="text-85" type="text"><inno:block page="5" page-height="512" page-width="396" x-max="304.0" x-min="118.0" y-max="330.9" y-min="324.0"><inno:nec bbox="187.6 282.43 192.65 286.36" cid="1" code="0xf0b7" fid="24:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Change in budget or deferral of capital projects/acquisitions</inno:font></inno:color></inno:block></inno:text><inno:text id="text-86" type="text"><inno:block page="5" page-height="512" page-width="396" x-max="236.0" x-min="119.0" y-max="341.0" y-min="331.0"><inno:nec bbox="187.6 268.93 192.65 272.86" cid="1" code="0xf0b7" fid="24:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Decrease in salaries/director fees</inno:font></inno:color></inno:block></inno:text><inno:text id="text-87" type="text"><inno:block page="5" page-height="512" page-width="396" x-max="186.0" x-min="119.0" y-max="350.0" y-min="342.0"><inno:nec bbox="187.6 255.43 192.65 259.36" cid="1" code="0xf0b7" fid="24:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Employee layoffs</inno:font></inno:color></inno:block></inno:text><inno:text id="text-88" type="text"><inno:block page="5" page-height="512" page-width="396" x-max="225.0" x-min="118.0" y-max="359.0" y-min="350.1"><inno:nec bbox="187.6 241.93 192.65 245.86" cid="1" code="0xf0b7" fid="24:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Additional oversight measures</inno:font></inno:color></inno:block></inno:text><inno:text id="text-89" type="text"><inno:block page="5" page-height="512" page-width="396" x-max="264.0" x-min="118.0" y-max="366.9" y-min="359.1"><inno:nec bbox="187.6 228.43 192.65 232.36" cid="1" code="0xf0b7" fid="24:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Modification of payment terms with suppliers</inno:font></inno:color></inno:block></inno:text><inno:text id="text-90" type="text"><inno:block page="5" page-height="512" page-width="396" x-max="232.0" x-min="119.0" y-max="376.0" y-min="367.0"><inno:nec bbox="187.6 214.93 192.65 218.86" cid="1" code="0xf0b7" fid="24:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">New or amended credit agreements</inno:font></inno:color></inno:block></inno:text><inno:text id="text-91" type="text"><inno:block page="5" page-height="512" page-width="396" x-max="237.0" x-min="118.0" y-max="389.0" y-min="376.1"><inno:nec bbox="187.6 201.43 192.65 205.36" cid="1" code="0xf0b7" fid="24:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Change in dividends or distributions<inno:br/><inno:nec bbox="187.6 187.93 192.65 191.86" cid="1" code="0xf0b7" fid="24:0"/> A i thi d t fi i</inno:font></inno:color></inno:block></inno:text><inno:text id="text-92" type="text"><inno:block page="5" page-height="512" page-width="396" x-max="259.0" x-min="117.0" y-max="402.0" y-min="389.1"><inno:nec bbox="187.6 187.93 192.65 191.86" cid="1" code="0xf0b7" fid="24:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">ccess ng t r party nanc ng<inno:br/><inno:nec bbox="187.6 174.43 192.65 178.36" cid="1" code="0xf0b7" fid="24:0"/> Implementation of business continuity plans</inno:font></inno:color></inno:block></inno:text><inno:text id="text-93" type="text"><inno:block page="5" page-height="512" page-width="396" x-max="238.0" x-min="119.0" y-max="410.9" y-min="403.0"><inno:nec bbox="187.6 160.93 192.65 164.86" cid="1" code="0xf0b7" fid="24:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Suspension of issuer share buybacks</inno:font></inno:color></inno:block></inno:text><inno:text id="text-94" type="text"><inno:block page="5" page-height="512" page-width="396" x-max="186.0" x-min="119.0" y-max="419.0" y-min="411.0"><inno:nec bbox="187.6 147.43 192.65 151.36" cid="1" code="0xf0b7" fid="24:0"/> <inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Disposal of assets</inno:font></inno:color></inno:block></inno:text><inno:text id="text-95" type="text"><inno:block page="5" page-height="512" page-width="396" x-max="351.0" x-min="42.0" y-max="470.0" y-min="437.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Most issuers reviewed were proactive in providing quality and detailed disclosures. For example, we<inno:br/>observed several issuers significantly expand their MD&amp;A to provide detailed operational updates<inno:br/>addressing the impact of COVID-19 as well as issuers providing additional disclosure addressing debt<inno:br/>covenants and related compliance. We also noted most issuers adequately disclosed impairments of non-</inno:font></inno:block></inno:text><inno:text id="text-96" type="text"><inno:block page="6" page-height="512" page-width="396" x-max="202.0" x-min="193.0" y-max="33.0" y-min="22.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-6-</inno:font></inno:block></inno:text><inno:text id="text-97" type="text"><inno:block page="6" page-height="512" page-width="396" x-max="349.0" x-min="43.0" y-max="62.0" y-min="41.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">financial assets due to a deterioration in their business since the onset of the pandemic. However, we<inno:br/>identified several areas where disclosure could be improved for many issuers including the following:</inno:font></inno:block></inno:text><inno:table id="table-1" type="table"><inno:block page="6" page-height="512" page-width="396" x-max="350.0" x-min="45.0" y-max="480.0" y-min="66.0"><inno:tr row="1">
<inno:td col="1" id="table-1-1-1" x-max="126.5" x-min="45.0" y-max="76.5" y-min="66.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Area of Disclosure</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-1-1-2" x-max="350.0" x-min="126.5" y-max="76.5" y-min="66.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Key Observations</inno:font></inno:b></inno:td>
</inno:tr>
<inno:tr row="2">
<inno:td col="1" id="table-1-2-1" x-max="126.5" x-min="45.0" y-max="178.0" y-min="76.5"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">MD&amp;A</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-1-2-2" rowspan="2" x-max="350.0" x-min="126.5" y-max="274.05" y-min="76.5"><inno:nec bbox="219.3 662.04 224.81 666.32" cid="1" code="0xf0b7" fid="24:0"/> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Discussion of measures taken to reduce COVID-19 impact</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">-<inno:br/>Many issuers provided “lists” of measures employed to manage<inno:br/>operational and liquidity risks but did not provide an adequate<inno:br/>discussion to address the anticipated impact to the issuer.</inno:font><inno:br/><inno:nec bbox="219.3 609.44 224.81 613.72" cid="1" code="0xf0b7" fid="24:0"/> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Analysis of overall performance and operations</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">- Most issuers<inno:br/>that quantitatively disclosed variances related to COVID-19 (e.g.,<inno:br/>impact to sales) did not explain the methodology used by<inno:br/>management in determining that fluctuations were isolated to<inno:br/>COVID-19.<inno:br/><inno:nec bbox="219.3 544.14 224.81 548.42" cid="1" code="0xf0b7" fid="24:0"/> Several issuers provided limited disclosure of known trends or<inno:br/>events related to COVID-19 that are likely to affect future<inno:br/>performance.</inno:font><inno:br/><inno:nec bbox="219.3 504.14 224.81 508.42" cid="1" code="0xf0b7" fid="24:0"/> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Liquidity and capital resources</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">- Many issuers with material<inno:br/>liquidity risks did not disclose in detail their ability to meet<inno:br/>working capital requirements, planned growth initiatives or to fund<inno:br/>developmental activities and capital expenditures. Lack of<inno:br/>disclosure regarding trends or expected fluctuations in liquidity<inno:br/>taking into account events or uncertainties related to COVID-19<inno:br/>was commonly observed.</inno:font><inno:br/><inno:nec bbox="219.3 413.54 224.81 417.82" cid="1" code="0xf0b7" fid="24:0"/> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Risk factor disclosure</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">- Several issuers provided “lists” of risks<inno:br/>without discussion or general disclosures that touched on general<inno:br/>economic or societal impacts of COVID-19 and did not describe<inno:br/>entity-specific COVID-19-related risks.</inno:font></inno:td>
</inno:tr>
<inno:tr row="3">
<inno:td col="1" id="table-1-3-1" rowspan="2" x-max="126.5" x-min="45.0" y-max="480.0" y-min="178.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Financial Statements</inno:font></inno:b></inno:td>
</inno:tr>
<inno:tr row="4">
<inno:td col="1" id="table-1-4-1" x-max="350.0" x-min="126.5" y-max="480.0" y-min="274.05"><inno:nec bbox="219.3 361.23 224.35 365.16" cid="1" code="0xf0b7" fid="24:0"/> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">General</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">- Some issuers failed to adequately update their<inno:br/>disclosures and assumptions impacted by COVID-19 in the context<inno:br/>of testing impairments of goodwill and intangible assets,<inno:br/>measuring fair value (</inno:font><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">FV</inno:font></inno:b><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">) and estimating expected credit losses.</inno:font><inno:br/><inno:nec bbox="219.3 309.83 224.35 313.76" cid="1" code="0xf0b7" fid="24:0"/> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Significant judgements and measurement uncertainties</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">– Some<inno:br/>issuers failed to include entity-specific disclosure for significant<inno:br/>judgements or measurement uncertainties or only included this<inno:br/>disclosure in their MD&amp;A but not in their financial statements.</inno:font><inno:br/><inno:nec bbox="219.3 258.33 224.35 262.26" cid="1" code="0xf0b7" fid="24:0"/> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Impairment of non-financial assets</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">– A few issuers did not<inno:br/>identify reasons for impairments or just noted “negative economic<inno:br/>impacts of COVID-19” as an impairment indicator for all cash<inno:br/>generating units (</inno:font><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">CGU</inno:font></inno:b><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">s) but did not elaborate on those impacts.</inno:font><inno:br/><inno:nec bbox="219.3 206.93 224.35 210.86" cid="1" code="0xf0b7" fid="24:0"/> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Going concern</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">- Some issuers breached financial covenants<inno:br/>during the reporting period but did not disclose the implications of<inno:br/>breaches on the issuer's ability to continue as a going concern.<inno:br/>Some issuers disclosed “close call” situations but did not disclose<inno:br/>the mitigating actions that impacted their determination that there<inno:br/>were no material uncertainties that cast significant doubt on the<inno:br/>issuer’s ability to continue as a going concern (e.g. successful<inno:br/>negotiation of credit facilities subsequent to period end).</inno:font><inno:br/><inno:nec bbox="219.3 104.83 224.35 108.76" cid="1" code="0xf0b7" fid="24:0"/> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Government assistance</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">- Over half of the issuers we reviewed<inno:br/>recognized, or disclosed in subsequent events, COVID-19 related<inno:br/>government assistance in their financial statements since the<inno:br/>outbreak of the COVID-19 pandemic. Some issuers did not<inno:br/>disclose the nature and extent of the government assistance or the</inno:font></inno:td>
</inno:tr>
</inno:block></inno:table><inno:text id="text-98" type="text"><inno:block page="7" page-height="512" page-width="396" x-max="201.0" x-min="194.0" y-max="33.0" y-min="24.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-7-</inno:font></inno:block></inno:text><inno:table id="table-2" type="table"><inno:block page="7" page-height="512" page-width="396" x-max="352.0" x-min="45.0" y-max="342.0" y-min="42.0"><inno:tr row="1">
<inno:td col="1" id="table-2-1-1" x-max="137.0" x-min="45.0" y-max="54.5" y-min="42.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Area of Disclosure</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-2-1-2" x-max="352.0" x-min="137.0" y-max="54.5" y-min="42.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Key Observations</inno:font></inno:b></inno:td>
</inno:tr>
<inno:tr row="2">
<inno:td col="1" id="table-2-2-1" x-max="137.0" x-min="45.0" y-max="152.0" y-min="54.5"/>
<inno:td col="2" id="table-2-2-2" x-max="352.0" x-min="137.0" y-max="152.0" y-min="54.5"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">accounting policy adopted including the methods of presentation.</inno:font><inno:br/><inno:nec bbox="219.3 688.23 224.35 692.16" cid="1" code="0xf0b7" fid="24:0"/> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Expected credit losses (ECL)</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">- Only a few issuers disclosed the<inno:br/>use of COVID-19-induced adjustments/overlays to their ECL<inno:br/>models.</inno:font><inno:br/><inno:nec bbox="219.3 649.43 224.35 653.36" cid="1" code="0xf0b7" fid="24:0"/> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Financial Instrument Risk Disclosure -</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Some issuers that<inno:br/>experienced material adverse impacts of COVID-19 did not<inno:br/>provide an entity-specific update to their risk disclosure in the<inno:br/>financial statements.</inno:font><inno:br/><inno:nec bbox="219.3 598.03 224.35 601.96" cid="1" code="0xf0b7" fid="24:0"/> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">COVID-19 related amendments to IFRS 16</inno:font> <inno:font font-name="TimesNewRomanPS-BoldItalicMT" font-size="11.00pt"><inno:i>Leases</inno:i></inno:font> <inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">for Lessees<inno:br/>–</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Certain issuers did not sufficiently disclose whether they applied<inno:br/>the practical expedient to either all or some of their rent<inno:br/>concessions.</inno:font></inno:td>
</inno:tr>
<inno:tr row="3">
<inno:td col="1" id="table-2-3-1" x-max="137.0" x-min="45.0" y-max="209.5" y-min="152.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">NGMs</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-2-3-2" x-max="352.0" x-min="137.0" y-max="209.5" y-min="152.0"><inno:nec bbox="219.3 546.03 224.35 549.96" cid="1" code="0xf0b7" fid="24:0"/> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">NGMs adjusted for COVID-19</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">- Most issuers did not present<inno:br/>NGMs that adjusted for the impact of COVID-19. However, our<inno:br/>review found isolated instances of potentially misleading NGMs in<inno:br/>relation to COVID-19 (e.g., adjusting for expenses attributable to<inno:br/>COVID-19 without adjusting for government subsidies or<inno:br/>“normalizing” revenue or expenses for the year-to-date period<inno:br/>based on more positive results for one quarter).</inno:font></inno:td>
</inno:tr>
<inno:tr row="4">
<inno:td col="1" id="table-2-4-1" x-max="137.0" x-min="45.0" y-max="252.05" y-min="209.5"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">FLI</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-2-4-2" x-max="352.0" x-min="137.0" y-max="252.05" y-min="209.5"><inno:nec bbox="219.3 456.83 223.89 460.4" cid="1" code="0xf0b7" fid="24:0"/> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">FLI related to COVID-19</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">- In certain cases, we observed<inno:br/>insufficient disclosure of assumptions used to develop FLI and<inno:br/>failure to adequately update the MD&amp;A for events and risks that<inno:br/>could cause actual results for future periods to differ materially<inno:br/>from previously disclosed FLI.</inno:font></inno:td>
</inno:tr>
<inno:tr row="5">
<inno:td col="1" id="table-2-5-1" x-max="137.0" x-min="45.0" y-max="301.5" y-min="252.05"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Material Change Reporting</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-2-5-2" x-max="352.0" x-min="137.0" y-max="301.5" y-min="252.05"><inno:nec bbox="219.3 392.43 224.35 396.36" cid="1" code="0xf0b7" fid="24:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">If COVID-19 has an equal effect throughout an issuer’s industry, a<inno:br/>material change report may not be required. Only a few issuers<inno:br/>reviewed filed material change reports in relation to COVID-19<inno:br/>although in some instances changes to the issuer’s business, operations<inno:br/>or capital were more unique or more significant to them than to others<inno:br/>in their industry.</inno:font></inno:td>
</inno:tr>
<inno:tr row="6">
<inno:td col="1" id="table-2-6-1" x-max="137.0" x-min="45.0" y-max="342.0" y-min="301.5"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Promotional Disclosures</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-2-6-2" x-max="352.0" x-min="137.0" y-max="342.0" y-min="301.5"><inno:nec bbox="219.3 315.13 224.35 319.06" cid="1" code="0xf0b7" fid="24:0"/> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Potentially misleading disclosures</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">- Some issuers concentrated in<inno:br/>the biotech/pharma industry provided disclosure in relation to<inno:br/>COVID-19 that was overly promotional and/or lacked specificity<inno:br/>to fully address the issuer’s business intentions and expected<inno:br/>milestones.</inno:font></inno:td>
</inno:tr>
</inno:block></inno:table><inno:text id="text-99" type="text"><inno:block page="7" page-height="512" page-width="396" x-max="352.0" x-min="43.0" y-max="411.0" y-min="349.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Please refer to</inno:font> <inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Appendix A – Key Observations and Disclosure Considerations –</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">for more detail<inno:br/>regarding the significant issues identified in our reviews and disclosure guidance. Please refer to</inno:font><inno:br/><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Appendix B – Disclosure Examples</inno:font></inno:b> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">where we have included some examples of deficient disclosure<inno:br/>contrasted against improved entity-specific disclosure. The observations and disclosure considerations<inno:br/>presented do not represent an exhaustive list and do not represent all the requirements that could apply to<inno:br/>a particular issuer’s situation. Issuers should consider their specific business and operations and provide<inno:br/>clear and transparent disclosure of the impact of COVID-19.</inno:font></inno:block></inno:text><inno:text id="text-100" type="text"><inno:block page="8" page-height="512" page-width="396" x-max="201.0" x-min="194.0" y-max="33.0" y-min="22.0"><inno:font font-name="TimesNewRomanPSMT" font-size="12.00pt">-8-</inno:font></inno:block></inno:text><inno:text id="text-101" type="text"><inno:block page="8" page-height="512" page-width="396" x-max="326.0" x-min="46.0" y-max="56.0" y-min="42.0"><inno:b><inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="16.00pt">Appendix A – Key Observations and Disclosure Considerations</inno:font></inno:color></inno:b></inno:block></inno:text><inno:text id="text-102" type="text"><inno:block page="8" page-height="512" page-width="396" x-max="133.0" x-min="43.0" y-max="74.0" y-min="62.0"><inno:b><inno:color rgb="#1e487c"><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="14.00pt">A.1 MD&amp;A Reporting</inno:font></inno:color></inno:b></inno:block></inno:text><inno:text id="text-103" type="text"><inno:block page="8" page-height="512" page-width="396" x-max="350.0" x-min="43.0" y-max="117.0" y-min="79.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">MD&amp;A is the cornerstone of a reporting issuer’s overall financial disclosure and should provide an<inno:br/>analytical and balanced discussion of the issuer’s results of operations and financial condition through the<inno:br/>eyes of management. MD&amp;A disclosure should be specific, useful and understandable. The MD&amp;A<inno:br/>requirements are set out in Form 51-102F1</inno:font> <inno:font font-name="TimesNewRomanPS-ItalicMT" font-size="11.00pt"><inno:i>Management’s Discussion and Analysis</inno:i></inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">(</inno:font><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Form 51-102F1</inno:font></inno:b><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">).</inno:font></inno:block></inno:text><inno:text id="text-104" type="text"><inno:block page="8" page-height="512" page-width="396" x-max="351.0" x-min="43.0" y-max="157.0" y-min="120.0"><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">Some of the observations and considerations below may be relevant for issuers that prepare an annual<inno:br/>information form (</inno:font><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">AIF</inno:font></inno:b><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">) with reference to Form 51-102F2</inno:font> <inno:font font-name="TimesNewRomanPS-ItalicMT" font-size="11.00pt"><inno:i>Annual Information Form</inno:i></inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">(</inno:font><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Form 51-102F2</inno:font></inno:b><inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">).<inno:br/>Specifically, issuers should consider additional disclosure for COVID-19 under Item 4-</inno:font><inno:font font-name="TimesNewRomanPS-ItalicMT" font-size="11.00pt"><inno:i>General<inno:br/>Development of the Business</inno:i></inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">and Item 5-</inno:font><inno:font font-name="TimesNewRomanPS-ItalicMT" font-size="11.00pt"><inno:i>Describe the Business</inno:i></inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="11.00pt">of Form 51-102F2.</inno:font></inno:block></inno:text><inno:table id="table-3" type="table"><inno:block page="8" page-height="512" page-width="396" x-max="366.0" x-min="45.0" y-max="475.0" y-min="161.0"><inno:tr row="1">
<inno:td col="1" id="table-3-1-1" x-max="106.0" x-min="45.0" y-max="171.0" y-min="161.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Focus Area</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-3-1-2" x-max="220.05" x-min="106.0" y-max="171.0" y-min="161.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Observations</inno:font></inno:b></inno:td>
<inno:td col="3" id="table-3-1-3" x-max="366.0" x-min="220.05" y-max="171.0" y-min="161.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Considerations</inno:font></inno:b></inno:td>
</inno:tr>
<inno:tr row="2">
<inno:td col="1" id="table-3-2-1" x-max="106.0" x-min="45.0" y-max="296.05" y-min="171.0"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">General: Discussion<inno:br/>of Operational<inno:br/>Status</inno:font></inno:b></inno:td>
<inno:td col="2" id="table-3-2-2" rowspan="2" x-max="220.05" x-min="106.0" y-max="466.95" y-min="171.0"><inno:nec bbox="176.7 508.03 181.29 511.6" cid="1" code="0xf0b7" fid="24:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Some issuers provided detailed<inno:br/>operational updates in press<inno:br/>releases but included limited<inno:br/>disclosure in MD&amp;A filings.</inno:font><inno:br/><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Useful disclosure observed:</inno:font></inno:b><inno:br/><inno:nec bbox="176.7 438.03 181.29 441.6" cid="1" code="0xf0b7" fid="24:0"/> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Many affected issuers significantly<inno:br/>expanded their MD&amp;A to explain<inno:br/>the impact of COVID-19 to the<inno:br/>issuer’s industry, operations,<inno:br/>customers, suppliers etc. Several<inno:br/>issuers disclosed industry and<inno:br/>relevant operational information to<inno:br/>help users frame and understand<inno:br/>the effects on the issuer’s financial<inno:br/>results.</inno:font></inno:td>
<inno:td col="3" id="table-3-2-3" x-max="366.0" x-min="220.05" y-max="296.05" y-min="171.0"><inno:font font-name="Calibri" font-size="10.00pt">•</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Provide a detailed and transparent discussion<inno:br/>on how COVID-19 has altered the issuer’s<inno:br/>industry and day to day operations. Insight<inno:br/>should be provided into the issuer’s current<inno:br/>operating status and the operational challenges<inno:br/>that management is monitoring. This will vary<inno:br/>materially by issuer and by industry.<inno:br/><inno:nec bbox="346.9 432.53 351.49 436.1" cid="1" code="0xf0b7" fid="24:0"/> MD&amp;A is a standalone document. Material<inno:br/>operational updates should be reflected in<inno:br/>MD&amp;A filings to provide additional context for<inno:br/>analyzing financial results. Having a separate<inno:br/>“COVID-19” section in the MD&amp;A preceding<inno:br/>the discussion of financial results may provide<inno:br/>a useful framework in understanding the<inno:br/>issuer’s analysis of financial performance,<inno:br/>financial condition and liquidity.</inno:font></inno:td>
</inno:tr>
<inno:tr row="3">
<inno:td col="1" id="table-3-3-1" x-max="106.0" x-min="45.0" y-max="466.95" y-min="296.05"/>
<inno:td col="2" id="table-3-3-2" x-max="366.0" x-min="220.05" y-max="466.95" y-min="296.05"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Issuers should consider:</inno:font></inno:b><inno:br/><inno:font font-name="Calibri" font-size="10.00pt">•</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Impact of health and safety guidelines on<inno:br/>operations and on how the issuer conducts its<inno:br/>business</inno:font><inno:br/><inno:font font-name="Calibri" font-size="10.00pt">•</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">How the current environment has altered<inno:br/>demand or ability to provide products and<inno:br/>services (both adversely and positively)</inno:font><inno:br/><inno:font font-name="Calibri" font-size="10.00pt">•</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Details of operational closures and restrictions</inno:font><inno:br/><inno:font font-name="Calibri" font-size="10.00pt">•</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Providing information to understand the impact<inno:br/>of shutdowns and closures</inno:font><inno:br/><inno:font font-name="Calibri" font-size="10.00pt">•</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Disclosing relevant industry data that assists<inno:br/>with understanding restrictions and other<inno:br/>impacts to the issuer’s business</inno:font><inno:br/><inno:font font-name="Calibri" font-size="10.00pt">•</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Discussing how customers and suppliers have<inno:br/>been impacted and the effect on the issuer</inno:font><inno:br/><inno:font font-name="Calibri" font-size="10.00pt">•</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Providing a discussion for each segment or<inno:br/>geographic location to the extent operations are<inno:br/>impacted differently</inno:font><inno:br/><inno:font font-name="Calibri" font-size="10.00pt">•</inno:font> <inno:font font-name="TimesNewRomanPSMT" font-size="10.00pt">Explaining how industry and economic factors<inno:br/>have uniquely impacted the issuer</inno:font></inno:td>
</inno:tr>
<inno:tr row="4">
<inno:td col="1" id="table-3-4-1" x-max="106.0" x-min="45.0" y-max="475.0" y-min="466.95"/>
<inno:td col="2" id="table-3-4-2" x-max="220.05" x-min="106.0" y-max="475.0" y-min="466.95"/>
<inno:td col="3" id="table-3-4-3" x-max="366.0" x-min="220.05" y-max="475.0" y-min="466.95"><inno:b><inno:font font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Reference: Part 1, Item 1.2, Item 1.4 of Form 51-</inno:font></inno:b></inno:td>
</inno:tr>
</inno:block></inno:table></inno:content></inno:dom>